Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "Formulations"

576 News Found

Cadila Pharmaceuticals marks 75-year journey of global healthcare innovation
News | March 16, 2026

Cadila Pharmaceuticals marks 75-year journey of global healthcare innovation

Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities


Aptar Pharma teams up with COVIRIX Medical to explore next-generation antiviral inhaler
R&D | March 16, 2026

Aptar Pharma teams up with COVIRIX Medical to explore next-generation antiviral inhaler

COVIRIX Medical says its broad-spectrum antiviral portfolio has already shown positive virology results against key pandemic threats


Syntis Bio launches first patient dosing for groundbreaking oral obesity therapy
Clinical Trials | March 05, 2026

Syntis Bio launches first patient dosing for groundbreaking oral obesity therapy

SYNT-101 is a once-daily oral pill engineered to redirect nutrient absorption beyond the small intestine’s duodenum


Zenex Animal Health makes strategic European play with VievePharm acquisition
Healthcare | March 02, 2026

Zenex Animal Health makes strategic European play with VievePharm acquisition

VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets


Eris Lifesciences partnership with Natco Pharma for Semaglutide launch in India
News | February 24, 2026

Eris Lifesciences partnership with Natco Pharma for Semaglutide launch in India

The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape


Surya Brasil eyes India expansion after 30% US growth
News | February 23, 2026

Surya Brasil eyes India expansion after 30% US growth

The new lineup features everything from the Color Fixation and Hair Therapy ranges to the Balanced Cleansing Shampoo and Nourishment & Protection Conditioner


FDA accepts Teva’s NDA for long-acting schizophrenia injection
Drug Approval | February 21, 2026

FDA accepts Teva’s NDA for long-acting schizophrenia injection

If approved, TEV-'749 could help address a significant unmet need in available schizophrenia treatment options by addressing the lack of viable long-acting olanzapine formulations


Lupin partners with Spektus Pharma to commercialize DeslaFlex antidepressant in Canada
News | February 17, 2026

Lupin partners with Spektus Pharma to commercialize DeslaFlex antidepressant in Canada

DeslaFlex is an innovative antidepressant formulation developed by Spektus using the proprietary Flexitab oral drug-delivery platform


Akums surges in Q3 FY26 with 15% revenue jump, bags key EU & UK nods
News | February 14, 2026

Akums surges in Q3 FY26 with 15% revenue jump, bags key EU & UK nods

Operational leverage kicked in during the quarter, with adjusted EBITDA rising 21% year-on-year to Rs 147 crore